Common Stock Warrants - Schedule of Warrants Activity (Details) - Warrant [Member] |
12 Months Ended |
---|---|
Dec. 31, 2020
$ / shares
shares
| |
Number of Shares, Outstanding | shares | |
Number of Shares, Warrants granted | shares | 7,511,650 |
Number of Shares, Warrants exercised | shares | |
Number of Shares, Outstanding | shares | 7,511,650 |
Number of Shares, Exercisable | shares | 7,511,650 |
Weighted Average Exercise Price, Outstanding | $ / shares | |
Weighted Average Exercise Price, Warrants granted | $ / shares | .25 |
Weighted Average Exercise Price, Warrants exercised | $ / shares | |
Weighted Average Exercise Price, Outstanding | $ / shares | 0.25 |
Weighted Average Exercise Price, Exercisable | $ / shares | $ 0.25 |
X | ||||||||||
- Definition Number of shares exercisable. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, exercisable. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, warrants exercised. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, warrants granted. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, outstanding. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|